Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus

[1] Piepoli MF(2016)2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J 37 2315-2381

[2] Hoes AW(2019)Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease Cardiovasc Diabetol 18 160-1913

[3] Agewall S(2002)Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 1903-2116

[4] Albus C(2015)A randomized trial of intensive versus standard blood-pressure control N Engl J Med 373 2103-1299

[5] Brotons C(2019)Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus Hypertension 73 1291-197

[6] Catapano AL(2020)Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study Cardiovasc Diabetol 19 181-905

[7] Cooney MT(2012)Effect of correcting for long-term variation in major coronary heart disease risk factors: relative hazard estimation and risk prediction in the Atherosclerosis Risk in Communities Study Ann Epidemiol 22 191-1334

[8] Corra U(2010)Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Lancet 375 895-235

[9] Cosyns B(2013)Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial Circulation 128 1325-982

[10] Deaton C(2014)Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases–relationships and comparisons with vascular markers of atherosclerosis Atherosclerosis 235 230-338

[1] Piepoli MF(2016)2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J 37 2315-2381

[2] Hoes AW(2019)Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease Cardiovasc Diabetol 18 160-1913

[3] Agewall S(2002)Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 1903-2116

[4] Albus C(2015)A randomized trial of intensive versus standard blood-pressure control N Engl J Med 373 2103-1299

[5] Brotons C(2019)Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus Hypertension 73 1291-197

[6] Catapano AL(2020)Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study Cardiovasc Diabetol 19 181-905

[7] Cooney MT(2012)Effect of correcting for long-term variation in major coronary heart disease risk factors: relative hazard estimation and risk prediction in the Atherosclerosis Risk in Communities Study Ann Epidemiol 22 191-1334

[8] Corra U(2010)Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Lancet 375 895-235

[9] Cosyns B(2013)Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial Circulation 128 1325-982

[10] Deaton C(2014)Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases–relationships and comparisons with vascular markers of atherosclerosis Atherosclerosis 235 230-338